Darbelife 200

Darbelife 200mcg Injection contains Darbepoetin Alfa as its active ingredient. This antineoplastic medication falls under the category of hematopoietic growth factors. It is prescribed for the treatment of anemia (reduced RBC count) in individuals suffering from chronic kidney disease. Additionally, it is indicated for managing anemia resulting from chemotherapy in patients with specific cancer types. Common symptoms of anemia include fatigue, weakness, and shortness of breath.

Do not use Darbelife 200mcg Injection if you are allergic to it or any of its components, and if you have uncontrolled hypertension. Notify your doctor if you have high blood pressure, anemia, a history of seizures, epilepsy, liver disease, or allergies to latex or hepatitis C. Also, inform your healthcare provider if you are pregnant or nursing.

If you experience severe headaches, dizziness, drowsiness, confusion, vision problems, nausea, vomiting, or seizures after administering Darbelife 200mcg Injection, contact your physician immediately and seek medical assistance. The most frequently reported side effects of this medication include hypertension, shortness of breath, leg swelling, and cough.